TECH BUYER Dec 2022 - IDC MarketScape - Doc # US48061622
IDC MarketScape: Worldwide Life Science R&D Pharmacovigilance Solutions 2022 Vendor Assessment
This IDC study focuses on a combination of PV technology solutions and consulting services. This IDC MarketScape provides a qualitative and quantitative assessment based on criteria that should be important to life science companies when considering the selection of a strategic PV solution provider to help provide guidance for strategic, operational, and tactical transformation issues within the PV space, as well as technology platforms, and build capabilities. This is the second time that an IDC MarketScape assessment of PV solutions for life science R&D has been performed.
Dr. Nimita Limaye, research VP, Life Science R&D Strategy and Technology at IDC, noted, "Pharmacovigilance has gained significant importance and a more visible public profile post the COVID-19 pandemic. The surge in the volume of cases, the need to accelerate innovation while ensuring patient safety, and the need to address the distrust that the pharma industry experienced during the pandemic, all call for a focused effort toward implementing a forward-looking PV strategy and adopting technology solutions that leverage cognitive automation, build compliance, drive efficiency, ensure patient safety, and build transparency and trust."
IDC Health Insights: Worldwide Life Science R&D Strategy and Technology
Sarjen Systems Pvt. Ltd., Oracle Corporation, NAVITAS CO., LTD., ArisGlobal LLC, Tata Consultancy Services Limited, Cognizant Technology Solutions Corporation, Accenture plc, Indegene Inc., PricewaterhouseCoopers LLP, IQVIA Inc., Veeva Systems Inc.
Analytic applications, Cognitive/artificial intelligence, Governance, risk and compliance infrastructure, IT consulting services, Integration and process automation middleware, Regulatory compliance, Robotics, Technology buyer
Health treatment strategies, Knowledge-based medicine
List of Tables
List of Figures
When you purchase this document, the purchase price can be applied to the cost of an annual subscription, giving you access to more research for your investment.